Back to Search
LORRIN KORAN, M.D.
M.D.
Psychiatry Physician
NPI: 1407911811Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Double-blind study of dextroamphetamine versus caffeine augmentation for treatment-resistant obsessive-compulsive disorder.
PMID 19573497·J Clin Psychiatry·2009
2-rct
The prevalence of body dysmorphic disorder in the United States adult population.
PMID 18408651·CNS Spectr·2008
8-other
Escitalopram treatment of kleptomania: an open-label trial followed by double-blind discontinuation.
PMID 17388713·J Clin Psychiatry·2007
2-rct
Duloxetine treatment of dysthymia and double depression: an open-label trial.
PMID 17503986·J Clin Psychiatry·2007
3-trial
Pulse-loaded intravenous clomipramine in treatment-resistant obsessive-compulsive disorder.
PMID 16415712·J Clin Psychopharmacol·2006
3-trial
Estimated prevalence of compulsive buying behavior in the United States.
PMID 17012693·Am J Psychiatry·2006
4-observational
Mirtazapine for obsessive-compulsive disorder: an open trial followed by double-blind discontinuation.
PMID 15816795·J Clin Psychiatry·2005
3-trial
Double-blind treatment with oral morphine in treatment-resistant obsessive-compulsive disorder.
PMID 15766302·J Clin Psychiatry·2005
3-trial
Citalopram for compulsive shopping disorder: an open-label study followed by double-blind discontinuation.
PMID 12934980·J Clin Psychiatry·2003
3-trial
Medical disorders among patients admitted to a public-sector psychiatric inpatient unit.
PMID 12461226·Psychiatr Serv·2002
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 401 QUARRY RD, OCD CLINIC, ROOM 2363
STANFORD, CA 94305 - Phone
- (650) 723-5154
Quick Facts
- NPI
- 1407911811
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile